Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients.
Mohamed YI, Duda DG, Awiwi MO, Lee SS, Altameemi L, Xiao L, Morris JS, Wolff RA, Elsayes KM, Hatia RI, Qayyum A, Chamseddine SM, Rashid A, Yao JC, Mahvash A, Hassan MM, Amin HM, Kaseb AO.
Mohamed YI, et al. Among authors: kaseb ao.
Oncotarget. 2022 Dec 6;13:1314-1321. doi: 10.18632/oncotarget.28322.
Oncotarget. 2022.
PMID: 36473155
Free PMC article.